Mylan Hit With Patent Suit Over FazaClo ANDA
Cima Labs Inc. and Azur Pharma Ltd. have sued Mylan Inc. in an effort to prevent the generics maker from releasing its own version of schizophrenia drug FazaClo....To view the full article, register now.
Already a subscriber? Click here to view full article